Plasma VWF: Ag levels predict long-term clinical outcomes in patients with acute myocardial infarction
Frontiers in Cardiovascular Medicine · 04.01.2023 · 9
DOI: 10.3389/fcvm.2022.1013815 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 04.01.2023. Verfasst von Zulipiyemu Xier und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
A vital role in coronary artery disease is played by Von Willebrand factor (VWF), which serves as a bridge between platelets and the subendothelial matrix after vessel damage. The purpose of the study was to assess the validity of plasma VWF antigen (VWF: Ag) levels as a predictor of clinical outcomes after acute myocardial infarction (AMI).
Methods
Three hundred and seventy-four patients were studied following coronary angiography, including 209 patients suffering from acute myocardial infarction and 165 healthy participants. Coronary angiography was followed by measurement of plasma VWF: Ag levels. Over a 2-year follow-up period, major adverse cardiopulmonary and cerebrovascular events (MACEs) were the primary endpoint. All-cause mortality was investigated as a secondary endpoint.
Results
When compared to controls, patients with AMI had mean plasma VWF: Ag levels that were ~1.63 times higher (0.860 ± 0.309 vs. 0.529 ± 0.258 IU/ml; P < 0.001). The plasma VWF: Ag levels were substantially higher in patients who experienced MACEs after myocardial infarction vs. those without MACEs (1.088 ± 0.253 vs. 0.731 ± 0.252 IU/ml; P < 0.001). For predicting long-term MACEs using the optimal cut-off value (0.7884 IU/ml) of VWF: Ag, ROC curve area for VWF: Ag was 0.847, with a sensitivity of 87.2% and a specificity of 66.3% (95%CI: 0.792–0.902; P = 0.001). Two-year follow-up revealed a strong link between higher plasma VWF: Ag levels and long-term MACEs. At the 2-year follow-up, multivariate regression analysis revealed an independent relationship between plasma VWF: Ag levels and MACEs (HR = 6.004, 95%CI: 2.987–12.070).
Conclusion
We found evidence that plasma VWF: Ag levels were independent risk factors for AMI. Meanwhile, higher plasma VWF: Ag levels are associated with long-term MACEs in people with AMI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China.
Zitieren
APA
Xier, Z., Zhu, Y. X., Tang, S. W., Kong, C., Aili, D., Huojia, G., & Peng, H. (2023). Plasma VWF: Ag levels predict long-term clinical outcomes in patients with acute myocardial infarction. Frontiers in Cardiovascular Medicine, 9. https://doi.org/10.3389/fcvm.2022.1013815
Vancouver
Xier Z, Zhu YX, Tang SW, Kong C, Aili D, Huojia G, et al. Plasma VWF: Ag levels predict long-term clinical outcomes in patients with acute myocardial infarction. Frontiers in Cardiovascular Medicine. 2023;9. doi:10.3389/fcvm.2022.1013815
BibTeX
@article{Xier2023,
author = {Xier, Zulipiyemu and Zhu, Yu-Xia and Tang, Shou-Wei and Kong, Can and Aili, Dilihumaer and Huojia, Guzailinuer and Peng, Hui},
title = {Plasma VWF: Ag levels predict long-term clinical outcomes in patients with acute myocardial infarction},
journal = {Frontiers in Cardiovascular Medicine},
year = {2023},
volume = {9},
doi = {10.3389/fcvm.2022.1013815}
}
EUVIMED